US Companion Diagnostics Market Trends and Insights

US Companion Diagnostics Market Trends and Insights

Technological Advances and Promising New Drug Classes Create New Market Opportunities

RELEASE DATE
22-Apr-2014
REGION
North America
Research Code: 9837-00-7C-00-00
SKU: LS00212-NA-MR_17472
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00212-NA-MR_17472

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests. This research deliverable discusses important trends in the U.S. companion diagnostics market including emerging opportunities with novel drug classes and new clinical markers like circulating tumor cells. Emerging therapeutic areas beyond oncology for companion diagnostics are also discussed along with key competitors, rx-cdx partnerships, regulatory overview, and therapeutic pipelines with companion biomarkers.

Table of Contents

Related Research
A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests. This research deliverable discusses important trends in the U.S. companion diagnostics market including emerging opportunities with novel drug classes and new clinical markers like circulating tumor cells. Emerging therapeutic areas beyond oncology for companion diagnostics are also discussed along with key competitors, rx-cdx partnerships, regulatory overview, and therapeutic pipelines with companion biomarkers.
More Information
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number 9837-00-7C-00-00
Is Prebook No